Skip to main content

Advertisement

SpringerLink
Log in

Advanced Techniques for the Use of Neurotoxins in Non-Surgical Facial Rejuvenation

  • Original Article
  • Non-Surgical Aesthetic
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Neurotoxins initially were used to treat hyperfunctional rhytids of the face, but now have been expanded to improve facial shaping, correct facial asymmetry and even improve skin texture and tone.

Methods

The clinical approach to non-surgical facial rejuvenation is approached into four anatomical regions: the upper face, midface, lower face and neck.

Results

The key muscles of the upper face include frontalis, orbicularis oculi, corrugator supercilii, procerus, depressor supercilii and temporalis. The muscles in the midface to be discussed include the levator labii superioris, levator labii superioris alaeque nasi, depressor anguli oris, depressor septi nasi and nasalis. Treatment of the lower face focuses on the orbicularis oris, mentalis, depressor anguli oris and masseter muscles. Finally, treatment of the neck region will be reviewed with emphasis on platysmal bands and necklace lines as well as the Nefertiti lift.

Conclusions

Non-surgical facial rejuvenation using neurotoxins should be performed safely and effectively in order to avoid and treat complications.

Level of Evidence V

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19
Fig. 20

Similar content being viewed by others

References

  1. Nanda S, Bansal S (2013) Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers. Indian J Dermatol Venereol Leprol 79(1):32–40. https://doi.org/10.4103/0378-6323.104667

    Article  PubMed  Google Scholar 

  2. Loos BM, Maas CS (2003) Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am 11(4):439–443. https://doi.org/10.1016/S1064-7406(03)00090-7

    Article  PubMed  Google Scholar 

  3. Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18(1):17–21. https://doi.org/10.1111/j.1524-4725.1992.tb03295.x

    Article  CAS  PubMed  Google Scholar 

  4. Walker TJ, Dayan SH (2014) Comparison and overview of currently available neurotoxins. J Clin Aesthet Dermatol 7(2):31–39

    PubMed  PubMed Central  Google Scholar 

  5. Kane MA (2005) The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation. Facial Plast Surg 21(1):55–64

    Article  CAS  Google Scholar 

  6. Greco TM, Ditre CM, Ozog DM (2017) Anatomy and aesthetic principles. In: Cohen JL, Ozog DM (eds) Botulinum toxins. Wiley, Hoboken, NJ. https://doi.org/10.1002/9781118661833.ch2

    Chapter  Google Scholar 

  7. Carruthers J, Carruthers A (2003) Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg 29(5):468–476

    PubMed  Google Scholar 

  8. Jia Z, Lu H, Yang X et al (2016) Adverse events of botulinum toxin type a in facial rejuvenation: a systematic review and meta-analysis. Aesthet Plast Surg 40(5):769–777. https://doi.org/10.1007/s00266-016-0682-1

    Article  Google Scholar 

  9. Sepehr A, Chauhan N, Alexander AJ, Adamson PA (2010) Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction. Aesthet Plast Surg 34(5):583–586. https://doi.org/10.1007/s00266-010-9511-0

    Article  Google Scholar 

  10. Scharschmidt D, Mirastschijski U, Preiss S, Brähler E, Fischer T, Borkenhagen A (2018) Body image, personality traits, and quality of life in botulinum toxin A and dermal filler patients. Aesthet Plast Surg 42(4):1119–1125. https://doi.org/10.1007/s00266-018-1165-3

    Article  Google Scholar 

  11. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf

  12. Kerscher M, Roll S, Becker A, Wigger-Alberti W (2012) Comparison of the spread of three botulinum toxin type A preparations. Arch Dermatol Res 304(2):155–161. https://doi.org/10.1007/s00403-011-1179-z

    Article  CAS  PubMed  Google Scholar 

  13. Bentivoglio AR, Del Grande A, Petracca M, Ialongo T, Ricciardi L (2015) Clinical differences between botulinum neurotoxin type A and B. Toxicon 107(Pt A):77–84. https://doi.org/10.1016/j.toxicon.2015.08.001

    Article  CAS  PubMed  Google Scholar 

  14. Carruthers J, Carruthers A (2004) Botulinum toxin A in the mid and lower face and neck. Dermatol Clin 22(2):151–158

    Article  CAS  Google Scholar 

  15. Lowe NJ, Yamauchi P (2004) Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Clin Dermatol 22(1):18–22

    Article  Google Scholar 

  16. Guyuron B, Huddleston S (1994) Aesthetic indications for botulinum toxin. Plast Reconstr Surg 93(5):913–918

    Article  CAS  Google Scholar 

  17. Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group (2004) Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg 114(6 Suppl 1S):22S. https://doi.org/10.1097/01.prs.0000144795.76040.d3

    Article  Google Scholar 

  18. Ferreira MC, Salles AG, Gimenez R, Soares MF (2004) Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases. Aesthet Plast Surg 28(6):441–444. https://doi.org/10.1007/s00266-004-0031-7

    Article  Google Scholar 

  19. Lowe NJ (1998) Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Dermatol Surg 24(11):1216–1218. https://doi.org/10.1111/j.1524-4725.1998.tb04100.x

    Article  CAS  PubMed  Google Scholar 

  20. Sundaram H, Signorini M, Liew S et al (2016) Global aesthetics consensus: botulinum toxin type A-evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg 137(3):518e–529e

    Article  CAS  Google Scholar 

  21. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103000s5307lbl.pdf

  22. Shetty MK, IADVL Dermatosurgery Task Force (2008) Guidelines on the use of botulinum toxin type A. Indian J Dermatol Venereol Leprol 74(Suppl:S13–22):13

    Google Scholar 

  23. Nettar K, Maas C (2011) Neuromodulators: available agents, physiology, and anatomy. Facial Plast Surg 27(6):517–522

    Article  CAS  Google Scholar 

  24. Beer JI, Sieber DA, Scheuer III JF, Greco TM (2016) Three-dimensional Facial Anatomy: Structure and Function as It Relates to Injectable Neuromodulators and Soft Tissue Fillers. Plast Reconstr Surg Glob Open 4(12 Suppl):e1175

    Article  Google Scholar 

  25. Yu KC, Nettar KD, Bapna S, Boscardin WJ, Maas CS (2012) Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA. Arch Facial Plast Surg 14(3):198–204. https://doi.org/10.1001/archfacial.2011.1142

    Article  PubMed  Google Scholar 

  26. Rohrich RJ, Ghavami A, Crosby MA (2007) The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg 120(6 Suppl):41S–54S

    Article  CAS  Google Scholar 

  27. Montes JR, Wilson AJ, Chang BL, Percec I (2016) Technical Considerations for Filler and Neuromodulator Refinements. Plast Reconstr Surg Glob Open 4(12 Suppl):e1178. https://doi.org/10.1097/GOX.0000000000001178

    Article  PubMed  PubMed Central  Google Scholar 

  28. Sparavigna A, Tenconi B, Giori AM, Bellia G, La Penna L (2019) Evaluation of the efficacy of a new hyaluronic acid gel on dynamic and static wrinkles in volunteers with moderate aging/photoaging. Clin Cosmet Investig Dermatol 12:81–90. https://doi.org/10.2147/CCID.S191935

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Kiranantawat K, Suhk JH, Nguyen AH (2015) The Asian eyelid: relevant anatomy. Semin Plast Surg 29(3):158–164. https://doi.org/10.1055/s-0035-1556852

    Article  PubMed  PubMed Central  Google Scholar 

  30. Yalçınkaya E, Cingi C, Söken H, Ulusoy S, Muluk NB (2016) Aesthetic analysis of the ideal eyebrow shape and position. Eur Arch Otorhinolaryngol 273(2):305–310. https://doi.org/10.1007/s00405-014-3356-0

    Article  PubMed  Google Scholar 

  31. Macdonald MR, Spiegel JH, Raven RB, Kabaker SS, Maas CS (1998) An anatomical approach to glabellar rhytids. Arch Otolaryngol Head Neck Surg 124(12):1315–1320. https://doi.org/10.1001/archotol.124.12.1315

    Article  CAS  PubMed  Google Scholar 

  32. Cho ES, Hwang JY, Kim ST (2013) A proposal to prevent the "Mephisto sign" side effect of botulinum toxin type A injection in chronic migraine. Yonsei Med J 54(6):1542–1544. https://doi.org/10.3349/ymj.2013.54.6.1542

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sundaram H Brow-shaping enhancement with botulinum neurotoxin type A. Medscape Educ Dermatol. https://www.medscape.org/viewarticle/738431

  34. Niamtu J (2018) Neuromodulators (Neurotoxins). In: Niamtu J (ed) Cosmetic facial surgery, 2nd edn. Elsevier, St. Louis, pp 533–568

    Chapter  Google Scholar 

  35. Redaelli A, Forte R (2003) How to avoid brow ptosis after forehead treatment with botulinum toxin. J Cosmet Laser Ther 5(3–4):220–222

    Article  CAS  Google Scholar 

  36. Klein AW (2004) Contraindications and complications with the use of botulinum toxin. Clin Dermatol 22(1):66–75

    Article  Google Scholar 

  37. Scheinfeld N (2005) The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face. Dermatol Online J 11(1):9

    PubMed  Google Scholar 

  38. Corcoran NM, Goldman EM (2019) Anatomy, head and neck, masseter muscle StatPearls [Internet]. StatPearls Publishing, Treasure Island

    Google Scholar 

  39. Shetty N, Malaviya RK, Gupta MK (2012) Management of unilateral masseter hypertrophy and hypertrophic scar-a case report. Case Rep Dent 2012:521427. https://doi.org/10.1155/2012/521427

    Article  PubMed  PubMed Central  Google Scholar 

  40. Snider CC, Amalfi AN, Hutchinson LE, Sommer NZ (2017) New insights into the anatomy of the midface musculature and its implications on the nasolabial fold. Aesthet Plast Surg 41(5):1083–1090. https://doi.org/10.1007/s00266-017-0889-9

    Article  Google Scholar 

  41. Rohrich RJ, Huynh B, Muzaffar AR, Adams WP Jr, Robinson JB Jr (2000) Importance of the depressor septi nasi muscle in rhinoplasty: anatomic study and clinical application. Plast Reconstr Surg 105(1):376–383 discussion 384–8

    Article  CAS  Google Scholar 

  42. Kane MA (2003) The effect of botulinum toxin injections on the nasolabial fold. Plast Reconstr Surg 112(5 Suppl):66S–72S discussion 73S–74S

    Article  Google Scholar 

  43. Schavelzon D, Blugerman G, Wexler G, Martinez L (2016) Botulinum Toxin in the Nasal Area. In: Serdev N (ed) Miniinvasive Techniques in Rhinoplasty. IntechOpen, London. https://doi.org/10.5772/62070

    Chapter  Google Scholar 

  44. Hwang WS, Hur MS, Hu KS et al (2009) Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod 79(1):70–77. https://doi.org/10.2319/091407-437.1

    Article  PubMed  Google Scholar 

  45. de Maio M, DeBoulle K, Braz A, Rohrich RJ (2017) Alliance for the future of aesthetics consensus committee. Facial assessment and injection guide for botulinum toxin and injectable hyaluronic acid fillers: focus on the midface. Plast Reconstr Surg 140(4):540e–550e. https://doi.org/10.1097/PRS.0000000000003716

    Article  CAS  PubMed  Google Scholar 

  46. Goldman A, Wollina U (2010) Elevation of the corner of the mouth using botulinum toxin type a. J Cutan Aesthet Surg 3(3):145–150. https://doi.org/10.4103/0974-2077.74490

    Article  PubMed  PubMed Central  Google Scholar 

  47. de Maio M, Wu WTL, Goodman GJ, Monheit G (2017) Alliance for the future of aesthetics consensus committee. Facial assessment and injection guide for botulinum toxin and injectable hyaluronic acid fillers: focus on the lower face. Plast Reconstr Surg 140(3):393e–404e

    Article  Google Scholar 

  48. de Maio M (2018) Myomodulation with injectable fillers: an innovative approach to addressing facial muscle movement. Aesthetic Plast Surg 42(3):798–814. https://doi.org/10.1007/s00266-018-1116-z

    Article  PubMed  PubMed Central  Google Scholar 

  49. Piccinin MA, Zito PM (2019) Anatomy, head and neck, lips StatPearls [Internet]. StatPearls Publishing, Treasure Island

    Google Scholar 

  50. Benedetto A (ed) (2011) Botulinum toxins in clinical aesthetic practice. CRC Press, London. https://doi.org/10.3109/9781841847559

    Book  Google Scholar 

  51. Wu DC, Fabi SG, Goldman MP (2015) Neurotoxins: current concepts in cosmetic use on the face and neck-lower face. Plast Reconstr Surg 136(5 Suppl):76S–79S

    Article  CAS  Google Scholar 

  52. Wise JB, Greco T (2006) Injectable treatments for the aging face. Facial Plast Surg 22(2):140–146

    Article  CAS  Google Scholar 

  53. Samizadeh S (2019) The ideals of facial beauty among Chinese aesthetic practitioners: results from a large national survey. Aesthetic Plast Surg 43(1):102–114. https://doi.org/10.1007/s00266-018-1241-8

    Article  PubMed  Google Scholar 

  54. Arora A, Sodhi A, Hegde S, Roy AK (2015) Masseter muscle hypertrophy associated with temporomandibular joint disorder-A case report. Am J Oral Med Radiol 2(3):110–114

    Google Scholar 

  55. Park KM, Choi E, Kwak EJ (2018) The relationship between masseter muscle thickness measured by ultrasonography and facial profile in young Korean adults. Imaging Sci Dent 48(3):213–221. https://doi.org/10.5624/isd.2018.48.3.213

    Article  PubMed  PubMed Central  Google Scholar 

  56. Levy PM (2015) Neurotoxins: current concepts in cosmetic use on the face and neck-jawline contouring/platysma bands/necklace lines. Plast Reconstr Surg 136(5 Suppl):80S–83S

    Article  CAS  Google Scholar 

  57. Kaplan JB (2019) Consideration of muscle depth for botulinum toxin injections: a three-dimensional approach. Plast Surg Nurs 39(2):52–58. https://doi.org/10.1097/PSN.0000000000000265

    Article  PubMed  Google Scholar 

  58. Fogli AL (2008) Skin and platysma muscle anchoring. Aesthet Plast Surg 32(3):531–541. https://doi.org/10.1007/s00266-007-9111-9

    Article  CAS  Google Scholar 

  59. Matarasso A, Matarasso SL, Brandt FS, Bellman B (1999) Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 103(2):645–655. https://doi.org/10.1097/00006534-199902000-00043

    Article  CAS  PubMed  Google Scholar 

  60. Matarasso A, Matarasso SL (2003) Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 112(5 Suppl):138S–140S. https://doi.org/10.1097/01.PRS.0000082203.65641.DD

    Article  PubMed  Google Scholar 

  61. Brandt FS, Boker A (2003) Botulinum toxin for rejuvenation of the neck. Clin Dermatol 21(6):513–520. https://doi.org/10.1016/j.clindermatol.2003.11.004

    Article  PubMed  Google Scholar 

  62. Kane MA, Monheit G (2017) The Practical Use of AbobotulinumtoxinA in Aesthetics. Aesthet Surg J 37(suppl_1):S12–S19. https://doi.org/10.1093/asj/sjw285

    Article  PubMed  PubMed Central  Google Scholar 

  63. Levy PM (2007) The 'Nefertiti lift': a new technique for specific re-contouring of the jawline. J Cosmet Laser Ther 9(4):249–252. https://doi.org/10.1080/14764170701545657

    Article  PubMed  Google Scholar 

  64. Benedetto A (ed) (2006) Botulinum toxin in clinical dermatology, 1st edn. Taylor & Francis, London

    Google Scholar 

  65. Chuang J, Barnes C, Wong BJF (2016) Overview of facial plastic surgery and current developments. Surg J (N Y) 2(1):e17–e28. https://doi.org/10.1055/s-0036-1572360

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, Division of Facial Plastic Reconstructive Surgery, Philadelphia College of Osteopathic Medicine, 4190 City Line Avenue, Philadelphia, PA, 19131, USA

    Jason E. Cohn

  2. Center of Excellence in Facial Cosmetic Surgery, 2 Bala Plaza, PL-15, Bala Cynwyd, PA, 19004, USA

    Timothy M. Greco

Authors
  1. Jason E. Cohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy M. Greco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason E. Cohn.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Ethical Standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cohn, J.E., Greco, T.M. Advanced Techniques for the Use of Neurotoxins in Non-Surgical Facial Rejuvenation. Aesth Plast Surg 44, 1788–1799 (2020). https://doi.org/10.1007/s00266-020-01691-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-020-01691-5

Keywords

Search

Navigation